Clinical Trials Browser

Phase 1/2 × Carcinoma, Ovarian Epithelial × denileukin diftitox × Clear all

NCT05200559 2024-12-05

T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors

Phase 1/2 Recruiting

Turcot syndrome, Carcinoma, Ovarian Epithelial